0001104659-22-073972.txt : 20220623 0001104659-22-073972.hdr.sgml : 20220623 20220623180100 ACCESSION NUMBER: 0001104659-22-073972 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220405 FILED AS OF DATE: 20220623 DATE AS OF CHANGE: 20220623 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Silverman Joshua CENTRAL INDEX KEY: 0001524858 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-40458 FILM NUMBER: 221036521 MAIL ADDRESS: STREET 1: IROQUOIS CAPITAL MANAGEMENT LLC STREET 2: 205 EAST 42ND ST - 20TH FL. CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Synaptogenix, Inc. CENTRAL INDEX KEY: 0001571934 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461585656 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 9732420005 MAIL ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: NEUROTROPE BIOSCIENCE, INC. DATE OF NAME CHANGE: 20130312 4/A 1 tm2219110-3_4aseq1.xml OWNERSHIP DOCUMENT X0306 4/A 2022-04-05 2022-04-06 0 0001571934 Synaptogenix, Inc. SNPX 0001524858 Silverman Joshua C/O SYNAPTOGENIX, INC., 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 1 0 0 0 Stock Option (Right to Buy) 2022-04-05 4 J 0 0 A Common Stock, par value $0.0001 per share 0 D This filing is deemed to amend the Form 4, which was filed on April 6, 2022, on behalf of Mr. Silverman, showing a grant of 1,500 stock options to purchase shares of common stock of Synaptogenix, Inc. on April 5, 2022, to reflect that such grant was null and void ab initio. /s/ Robert Weinstein, Attorney-in-fact 2022-06-23